Document:

Exhibit 10.1

 

Offer Letter to James A. Schoeneck

 

April 3, 2011

 

Mr. James A. Schoeneck

 

[address]

 

Dear Jim:

 

On behalf of the Board of Directors, I am very pleased to extend to you this offer to become Depomed’s President and Chief Executive Officer.

 

Your initial rate of pay as President and Chief Executive Officer will be $540,000 per year.  Your salary will be reviewed periodically, consistent with the Company’s compensation policies.  You will receive no additional compensation for your service as a Director.

 

In connection with your appointment as President and Chief Executive Officer, the Compensation Committee of the Board of Directors has approved, effective upon your first day of employment, the grant to you of an option to purchase  500,000  shares of common stock (the “Option”) with an exercise price equal to the closing sale price of the common stock on the Nasdaq Global Market on your first day of employment (the “Closing Price”) that vests 12 and one-half  percent on the date that is six months following the date of grant and in equal monthly installments thereafter over the next forty-two months, such that the Option will be fully vested and exercisable on the anniversary of the grant date in 2015.  The Option will be subject to the terms and conditions set forth in the Company’s 2004 Equity Incentive Plan, the grant document and the Management Continuity Agreement to be entered into between you and Depomed (the “Management Continuity Agreement”).

 

Effective upon your first day of employment, you will be entitled to a sign-on bonus of $125,000.  You will also be entitled to participate in Depomed’s Bonus Plan, with a bonus target of 55 percent of your base salary, subject to the achievement of corporate and personal goals.  The annual bonus will be pro-rated for any partial year of employment.

 

You will be eligible to receive relocation assistance, as follows:

 

(1) Subject to paragraph (2) immediately below, should you relocate your residence to the San Francisco area within 24 months of your initial hire date and subject to the limitations set forth herein, the Company will reimburse you for reasonable out-of-pocket residence relocation expenses incurred by you in connection with the your residence relocation to the San Francisco area; provided, however, that with respect to any such residence relocation expenses that

 

 

constitute taxable income to you, the Company will reimburse such expense and pay you an additional amount equal to 55% of such expense.  Your residence relocation expenses eligible for reimbursement may include those incurred in connection with the sale of your current residence, expenses associated with your move of household goods to San Francisco, up to two house hunting trips to San Francisco for your family, and the final residence relocation trip to San Francisco for you and your family.  Additionally, the Company will reimburse you for the transaction costs associated with the purchase of a new residence in the San Francisco area, which may include not more than a total of 1% of the purchase price of the residence for mortgage origination fees or “points,” and other fees or services incurred in connection with establishing a new residence, for example, utility company fees.  In order to be eligible for reimbursement, you must provide receipts or other appropriate documentation of such expenses to the Company no later than ninety (90) following incurring such expenses.  The Company will make all expense reimbursement payments (including any applicable corresponding tax gross-up payment) within thirty (30) days of your submission of such expense documentation to the Company.  In connection with any residence relocation reimbursed by the Company, you will consult with the Company regarding the type and amount of anticipated reimbursable relocation expenses in advance of incurring such expenses.

 

(2) In addition, prior to your relocation to the San Francisco area, you will receive an additional monthly transition payment equal to $7,000, payable for 12 months.  If, after 12 months following your initial hire date you choose not to relocate your residence, you will receive $7,000 a month for an additional six months, but will not be eligible to receive residence relocation assistance.  Such monthly transition payments will be subject to all tax withholding.

 

In the event you incur an Involuntary Termination (as such term is defined in the Management Continuity Agreement) prior to a Change in Control (as such term is defined in the Management Continuity Agreement), subject to your execution of a release in a form reasonably satisfactory to the Company and the expiration of the statutory revocation period, you will be entitled to receive a severance payment equal to one year of your base salary.  Payment will be made periodically, in accordance with the Company’s standard payroll practice, beginning on the first payroll date that is 30 days from your last day worked.  Severance payments will be payable for one (1) year; provided however, that severance payments otherwise payable pursuant to this paragraph will be reduced dollar for dollar by any compensation received by you in connection with employment by another employer during the period of such payments.  Self-employment, including consulting services provided by you that are less than full-time, will not constitute employment by another employer.  You agree to immediately notify the Company of such compensation.  For purposes of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), each installment payment will be considered a separate payment.  In addition, if you elect to continue group health insurance coverage upon your separation from service, then the Company will continue to pay on your behalf the portion of the monthly premium that the Company contributes to your healthcare premiums immediately prior to your termination of employment until the earlier of (A) one (1) year or (B) the date you become eligible for health insurance in connection with your new employment.  Notwithstanding the foregoing, in the event

 

2

 

the Board of Directors concludes in its reasonable judgment that the provision of subsidized COBRA benefits to you could cause the Company to become subject to excise tax as a result of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, the Company shall pay you a monthly amount in cash equal to the amount of the COBRA subsidy during the period the Company is obligated to provide you with subsidized COBRA benefits.  Further you will be granted additional vesting in your Option, any additional options to purchase common stock and any restricted stock or restricted stock units subject to vesting as if you had continued employment with the Company for an additional three-month period.  For clarity, in no event will you be entitled to receive severance payments under both this letter and the Management Continuity Agreement.

 

Notwithstanding anything contrary in the foregoing, to the extent any payment that is contingent on your separation from service would be considered deferred compensation subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(i) of the Code, such payment will not be payable until the date that is the earlier of (A) six months and one day after your separation from service or (B) your death.  Any delayed payments will be made in the seventh month after your separation from service.

 

You will also participate in the Company’s complete benefits package, subject to the terms and conditions of each benefit plan.

 

You may continue your existing board memberships, but may not join any additional boards without consent of the Board of Directors.

 

For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States.  Such documentation must be provided to us within three business days of your date of hire, or our employment relationship with you may be terminated.

 

If you have not already done so, please disclose to the Company any agreements relating to your prior employment that may affect your eligibility to be employed by the Company or limit the manner in which you may be employed.  The Company understands that any such agreements will not prevent you from performing the duties of your position and you represent that such is the case.  You agree not to bring any third party confidential information to the Company, including that of your former employer, and that in performing your duties for the Company you will not in any way utilize any such information.

 

All our employees are required to sign an Employee Confidentiality and Invention Assignment Agreement.  You will be expected to enter into our standard Employee Confidentiality and Invention Assignment Agreement upon the commencement of your employment.

 

3

 

This offer will expire at 7 p.m. local time on April 3, 2011.  If you elect to accept this offer, please sign and return one copy of this letter to me by fax.

 

	
On   behalf of the Board of Directors,
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/   Peter Staple
    	
 
    	
 
    
	
Peter   Staple, Chairman of the Board of Directors
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
This   letter correctly sets forth our agreement:
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
/s/   James A. Schoeneck
    
	
 
    	
 
    	
James   A. Schoeneck
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Date:   April 3, 2011
    

 

4Exhibit 10.2

 

Separation Agreement and Release with Carl A. Pelzel

 

April 1, 2011

 

Carl A. Pelzel

[address]

 

Separation Agreement and Release

 

Dear Carl:

 

As we discussed, this letter confirms your separation from employment with Depomed, Inc. (the “Company”).

 

Your employment with the Company will terminate or has terminated on April 3, 2011 as a result of your resignation.  The Company shall provide you with the right to continue group health insurance coverage after your separation from employment under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”).  The terms for that opportunity will be set forth in a separate written notice.  The Company shall also reimburse you for any outstanding, reasonable business expenses that you have incurred on the Company’s behalf through your separation from employment, after the Company’s timely receipt of appropriate documentation pursuant to the Company’s business expense reimbursement policy.

 

The remainder of this letter proposes an agreement (the “Agreement”) between you and the Company.  The purpose of this Agreement is to establish an amicable arrangement for ending your employment relationship, including releasing the Company and related persons or entities from any claims and permitting you to receive separation pay and related benefits.

 

If you agree to the terms of this Agreement, you acknowledge that you are entering into this Agreement voluntarily.  It is customary in employment separation agreements for the departing employee to release the employer from any possible claims, even if the employer believes, as is the case here, that no such claims exist.  By entering into this Agreement, you understand that neither party is admitting in any way that it violated any legal obligation owed to the other party.

 

With those understandings, you and the Company agree as follows:

 

1.                                                                                                                                       Separation from Employment

 

This confirms that your employment with the Company will end or has ended on April 3, 2011 (the “Separation Date”).  Effective on the Separation Date, it is agreed that you have resigned as an employee, from your positions as President and Chief Executive Officer and from the Company’s Board of Directors.

 

 

2.                                                                                                                                       Separation Benefits

 

a.  Severance Pay.  You will be paid a severance payment of $520,000, less all applicable withholdings, which is equivalent to one year of your base pay.  Payment will be made periodically, in accordance with the Company’s standard payroll practice, beginning on the first payroll date that is thirty (30) days from the date hereof.  Severance payments will be payable for one (1) year; provided, that severance payments otherwise payable pursuant to this paragraph will be reduced dollar for dollar by any compensation received by you in connection with employment by another employer during the period of such payments.  Self-employment, including consulting services provided by you that are less than full time, will not constitute employment by another employer.  You agree to immediately notify the Company of such compensation.  For purposes of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), each installment payment is a separate payment.  You agree that prior to the execution of this Agreement you were not entitled to receive any further monetary payments or benefits from the Company, and that the only payments and benefits that you are entitled to receive from the Company in the future are those specified in this Agreement.

 

b.  Company-Paid COBRA.  As stated above, you will receive information about your right to continue your group health insurance coverage under COBRA after the Separation Date.  In order to continue your coverage, you must file the required election form.  If you sign this Agreement and elect to continue group health insurance coverage, then the Company will pay the monthly premium to its third party COBRA Administrator under COBRA, in an amount not to exceed the monthly amount the Company currently contributes to your healthcare premiums, for yourself and, if applicable, your dependents, until the earliest of (a) September 30, 2012, (b) the expiration of your eligibility for continuation coverage under COBRA or (c) the date when you become eligible for comparable health insurance in connection with new employment.  You acknowledge that you otherwise would not have been entitled to any continuation of Company-paid health coverage.

 

3.                                                                                                                                       Return of Property

 

You confirm that, to the best of your knowledge, you have returned to the Company all Company property, including, without limitation, computer equipment/laptop, software, keys and access cards, credit cards, files and any documents (including computerized data and any copies made of any computerized data or software) containing information concerning the Company, its business or its business relationships (in the latter two cases, actual or prospective).  You also commit to deleting and finally purging any duplicates of files or documents that may contain Company information from any computer or other device that remains your property.  In the event that you discover that you continue to retain any such property, you shall return it to the Company immediately, except that you may retain your company-issued laptop computer and mobile phone, subject to your compliance with the other provisions of this Section.

 

4.                                                                                                                                       Proprietary Information Agreement

 

You acknowledge and agree that you are bound by and will comply with the Employee Confidentiality and Invention Assignment Agreement (the “Proprietary Information

 

2

 

Agreement”) that you have signed with the Company.  That Proprietary Information Agreement shall remain in full force and effect to the extent not inconsistent with this Agreement.

 

5.                                                                                                                                       Stock Options

 

The Company has granted you options under the Company’s 2004 Equity Incentive Plan.  Following the Effective Date, the vesting of any unvested options you hold as of your termination date will be accelerated by three months, such that the number of shares with respect to which your options will be exercisable will be equivalent to the number of shares exercisable were your termination of employment to occur on July 3, 2011.  You acknowledge that to the extent any of the options subject to accelerated vesting constitute incentive stock options, your acceptance of the accelerated vesting provided in the immediately preceding sentence may cause the incentive stock options to be disqualified and be treated as nonqualified stock options.

 

6.                                                                                                                                       Release of Claims

 

In consideration for, among other terms, the Severance Benefits described in Section 2 and the stock option acceleration and extended option exercise period described in Section 5, to which you acknowledge you would otherwise not be entitled, you voluntarily release and forever discharge the Company, its affiliated and related entities, its and their respective predecessors, successors and assigns, its and their respective employee benefit plans and fiduciaries of such plans, and the current and former officers, directors, shareholders, employees, attorneys, accountants and agents of each of the foregoing in their official and personal capacities (collectively referred to as the “Releasees”)  generally from all claims, demands, debts, damages and liabilities of every name and nature, known or unknown (“Claims”) that, as of the date when you sign this Agreement, you have, ever had, now claim to have or ever claimed to have had against any or all of the Releasees.  This release includes, without limitation, all Claims:

 

·                  relating to your employment by and termination of employment with the Company;

·                  of wrongful discharge;

·                  of breach of contract;

·                  of retaliation or discrimination under federal, state or local law (including, without limitation, Claims of age discrimination or retaliation under the Age Discrimination in Employment Act, Claims of disability discrimination or retaliation under the Americans with Disabilities Act, and Claims of discrimination or retaliation under Title VII of the Civil Rights Act of 1964);

·                  under any other federal or state statute;

·                  of defamation or other torts;

·                  of violation of public policy;

·                  for wages, bonuses, incentive compensation, stock, stock options, or any other benefits; and

·                  for damages or other remedies of any sort, including, without limitation, compensatory damages, punitive damages, injunctive relief and attorney’s fees;

 

provided, however, that this release shall not affect your rights under this Agreement or any right to indemnification granted by any agreement or bylaw of the Company, state or federal law, or policy of insurance.

 

3

 

You agree that you shall not accept damages of any nature, other equitable or legal remedies for your own benefit, attorney’s fees, or costs from any of the Releasees with respect to any Claim released by this Agreement.  As a material inducement to the Company to enter into this Agreement, you represent that you have not assigned to any third party and you have not filed with any agency or court any Claim released by this Agreement.

 

The Company is not currently aware of any matters that may give rise to a claim against you.

 

7.                                                                                                                                       Release of Unknown Claims

 

In granting the release herein, you understand that this Agreement includes a release of all claims known or unknown.  In giving this release, which includes claims which may be unknown to you at present, you acknowledge that you have read and understand Section 1542 of the California Civil Code which reads as follows:  “A general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have materially affected his or her settlement with the debtor.”  You hereby expressly waive and relinquish all rights and benefits under that section and any law of any jurisdiction of similar effect with respect to the release of any unknown or unsuspected claims you may have against the Company.

 

8.                                                                                                                                       Nondisparagement

 

You agree not to make any disparaging statements concerning the Company (including without limitation the Company’s products, its current or future business plans or its prospects) or any of its affiliates or current or former officers, directors, shareholders, employees or agents.  You further agree to direct to the Company any inquiries concerning the Company from the Company’s current or former employees, shareholders, business partners or vendors.  The Company agrees to instruct its officers and directors not to make any disparaging statements concerning you.  The obligations set forth in this Section 8 shall not in any way affect anyone’s obligation to testify truthfully in any legal proceeding.

 

9.                                                                                                                                       Legal Representation

 

This Agreement is a legally binding document and your signature will commit you to its terms.  You acknowledge that you have been advised to discuss all aspects of this Agreement with your attorney, that you have carefully read and fully understand all of the provisions of this Agreement and that you are voluntarily entering into this Agreement.

 

10.                                                                                                                                 Absence of Reliance

 

In signing this Agreement, you are not relying upon any promises or representations made by anyone at or on behalf of the Company, except as may be set forth in this Agreement.

 

11.                                                                                                                                 Enforceability

 

If any portion or provision of this Agreement (including, without limitation, any portion or provision of any section of this Agreement) shall to any extent be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of this Agreement, or the

 

4

 

application of such portion or provision in circumstances other than those as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each portion and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.

 

12.                                                                                                                                 Waiver

 

No waiver of any provision of this Agreement shall be effective unless made in writing and signed by the waiving party.  The failure of any party to require the performance of any term or obligation of this Agreement, or the waiver by any party of any breach of this Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a waiver of any subsequent breach.

 

13.                                                                                                                                 Governing Law; Interpretation

 

This Agreement shall be interpreted and enforced under the laws of the state of California, without regard to conflict of law principles.  In the event of any dispute, this Agreement is intended by the parties to be construed as a whole, to be interpreted in accordance with its fair meaning, and not to be construed strictly for or against either you or the Company or the “drafter” of all or any portion of this Agreement.

 

14.                                                                                                                                 Attorneys’ Fees and Costs

 

In the event that either Party brings an action to enforce or effect its rights under or relating to this Agreement, the prevailing Party shall be entitled to recover its costs and expenses, including the costs of mediation, arbitration, litigation, court fees, and reasonable attorneys’ fees incurred in connection with such an action.

 

15.                                                                                                                                 Entire Agreement

 

This Agreement constitutes the entire agreement between you and the Company.  This Agreement supersedes any previous agreements or understandings between you and the Company, except for the Proprietary Information Agreement, which remains in full force and effect, to the extent not inconsistent with this Agreement.

 

16.                                                                                                                                 Time for Consideration; Effective Date

 

You have the opportunity to consider this Agreement for twenty-one (21) days before signing it.  To accept this Agreement, you must sign this Agreement no earlier than the Separation Date and return a signed original of this Agreement so that it is received by the undersigned at or before the expiration of this twenty-one (21) day period.  If you sign this Agreement within less than twenty-one (21) days of the date of its delivery to you, you acknowledge by signing this Agreement that such decision was entirely voluntary and that you had the opportunity to consider this Agreement for the entire twenty-one (21) day period.  For the period of seven (7) days from the date when this Agreement becomes fully executed, you have the right to revoke this Agreement by written notice to the undersigned.  For such a revocation to be effective, it must be delivered so that it is received by the undersigned at or before the expiration of the seven (7) day revocation period.  This Agreement shall not become effective or enforceable during the

 

5

 

revocation period.  This Agreement shall become effective on the first business day following the expiration of the revocation period (the “Effective Date”).

 

17.                                                                                                                                 Counterparts

 

This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be taken to be an original, but all of which together shall constitute one and the same document.

 

18.                                                                                                                                 Section 409A

 

Anything in this Agreement to the contrary notwithstanding, to the extent any payment under this Agreement would be considered deferred compensation subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment will not be payable until the date that is the earlier of (A) six months and one day after your separation from service or (B) your death. Any delayed payments will be made in the seventh (7th) month after your separation from service.

 

Please indicate your agreement to the terms of this Agreement by signing and returning to me the original of this letter within the time period set forth above.

 

	
Very   truly yours,
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
Depomed, Inc.
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
By:
    	
/s/ Peter D. Staple
    	
 
    	
 
    
	
 
    	
Peter D. Staple
    	
 
    	
 
    
	
 
    	
Chairman of the Board of   Directors
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
The   foregoing is agreed to and accepted by:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/ Carl A. Pelzel
    	
 
    	
April 1, 2011
    
	
Carl A. Pelzel
    	
 
    	
Date
    

 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00189-of-00352.parquet"}]]